-
ADMA Biologics' (ADMA) "Overweight" Rating Reaffirmed at Cantor Fitzgerald
ソース: Buzz FX / 04 3 2025 10:36:16 America/New_York
ADMA Biologics' (ADMA) "Overweight" Rating Reaffirmed at Cantor Fitzgerald Written by MarketBeat March 4, 2025 Share Link copied to clipboard. ADMA Biologics ( NASDAQ:ADMA - Get Free Report ) 's stock had its "overweight" rating reiterated
Read more...